![]() |
|
|
Vol. 289, Issue 2, 768-773, May 1999
Faculty of Pharmaceutical Sciences,
| |
Abstract |
|---|
|
|
|---|
In the present study, functional characteristics of organic cation transporter (OCTN)1, which was cloned as the pH-dependent tetraethylammonium (TEA) transporter when expressed in mammalian human embryonic kidney (HEK)293 cells, were further investigated using Xenopus oocytes as well as HEK293 cells as gene expression systems. When OCTN1-derived complementary RNA was injected into Xenopus oocytes, pH-dependent transport of [14C]TEA was observed as the same in HEK293 cells. In contrast, a replacement of sodium ions with potassium ions in the surrounding medium did not cause any change in [14C]TEA uptake in Xenopus oocytes expressed with OCTN1. In addition, when OCTN1 was expressed in HEK293 cells, efflux of TEA from the cells was pH dependent, with an accelerated rate at acidic external medium pH. Accordingly, membrane potential or sodium ions are suggested to have no influence on [14C]TEA transport and the transport activity of OCTN1 is directly affected by pH itself. Furthermore, addition of the unlabeled TEA in external medium enhanced the efflux of preloaded [14C]TEA. These observations suggest that OCTN1 is a pH-dependent and bidirectional TEA transporter. OCTN1-mediated [14C]TEA uptake was inhibited by various organic cations such as cimetidine, procainamide, pyrilamine, quinidine, quinine, and verapamil. In addition, uptakes of cationic compounds such as [3H]pyrilamine, [3H]quinidine, and [3H]verapamil and zwitterionic L-[3H]carnitine were increased by expression of OCTN1 in Xenopus oocytes. Accordingly, OCTN1 was functionally demonstrated to be a multispecific and pH-dependent organic cation transporter, which presumably functions as a proton/organic cation antiporter at the renal apical membrane and other tissues.
| |
Introduction |
|---|
|
|
|---|
Renal
organic cation transporters are responsible for the secretion of
endogenous amines as well as various drugs. Studies using isolated
renal membrane vesicles suggested that organic cations are transported
by distinct mechanisms in brush-border and basolateral membranes. The
first step in organic cation secretion, uptake across the basolateral
membrane, involves membrane potential-dependent transporters (Koepsell,
1998
; Zhang et al., 1998
). This transport process is independent of
sodium ion or proton gradient and appears to be due to the recently
cloned organic cation transporters (OCT), OCT1 and OCT2 (Koepsell,
1998
). The second step of renal secretion, the transport across the
brush-border membrane, is performed at least by three transport
systems: a multispecific proton/organic cation antiporter that
transports tetraethylammonium (TEA), a more specific proton/organic
cation antiporter that transports guanidine (Miyamoto et al., 1989
;
Chun et al., 1997
), and the P-glycoprotein (Thiebaut et al., 1987
;
Fojo et al. 1987
; Tanigawara et al., 1992
; Schinkel et al.,
1994
). By means of membrane transport experiments using isolated
membrane vesicles, TEA, N-methylnicotinamide (NMN), choline,
procainamide, cimetidine, and aminocephalosporins have been
demonstrated to be substrates of the multispecific proton/organic cation antiporter (Koepsell, 1998
), which may be partially driven by
the sodium/proton exchanger (Takano et al., 1984
; Wright and Wunz,
1987
). Furthermore, interaction between TEA and levofloxacin on the
apical proton/organic cation antiport system in LLC-PK1 cells
has been observed (Ohtomo et al., 1996
), suggesting that the
transporter with broad substrate specificity may also be involved in
organic cation transport at the renal apical membrane. Although Gründemann et al. (1997)
suggested that porcine OCT2 is an
apical-type transporter on the basis of its susceptibility to specific
transport inhibitors and the pH dependence of TEA uptake in
OCT2-transfected human embryonic kidney (HEK)293 cells, Okuda et al.
(1996)
found a negligible pH-dependent transport of rat OCT2 in
complementary RNA (cRNA)-injected Xenopus oocytes and
suggested that it is a basolateral, not an apical, membrane
transporter. Human OCT2 was also cloned recently and was implicated in
pH-independent, membrane potential-dependent transport at the luminal
surface of distal tubules (Gorboulev et al., 1997
), whereas
immunohistochemical studies indicated that rat OCT1 and OCT2 are
localized at the basolateral membrane of proximal tubules (Koepsell,
1998
). Accordingly, the OCT1 and OCT2 family is presumed to function
for either reabsorption at the brush-border membrane or secretion at
the basolateral membrane of organic cationic compounds. So far, the
proton/organic cation antiporter in the renal apical membrane has not
been fully characterized at the molecular level.
We recently determined the primary structure of an organic cation
transporter, human OCTN1 (Tamai et al., 1997
). Human OCTN1 encodes a
551-amino acid protein with 11 putative transmembrane domains and is
present at several adult tissues, including kidney and skeletal muscle.
The degrees of similarity of human OCTN1 with rat OCT1
(Gründemann et al., 1994
), rat OCT2 (Okuda et al., 1996
), human
OCT1 (Zhang et al., 1997
), human OCT2 (Gorboulev et al., 1997
), and rat
OCT3 (Kekuda et al., 1998
) in amino acid sequences were 32%, 33%,
31%, 33%, and 36%, respectively. Accordingly, human OCTN1 was
considered to be a new member of the organic cation transporter family.
The OCTN1-induced TEA uptake in HEK293 cells was pH dependent and the
apparent Km was nearly identical with that of pH-dependent TEA uptake in renal brush-border membrane vesicles
of rat (Takano et al., 1984
; Wright and Wunz, 1987
; Maeda et al., 1993
;
Tamai et al., 1997
). Therefore, although its subcellular localization
has not yet been established, OCTN1 is thought to be responsible for
the efflux of organic cations across the renal epithelial brush-border
membrane. However, Kekuda et al. (1998)
reported that rat OCT3-mediated
TEA transport was markedly influenced by extracellular pH in HeLa
cells, and when OCT3 was expressed in Xenopus oocytes, the
induced TEA transport was electrogenic. This phenomenon could be
explained by the change of membrane potential due to the change in
extracellular pH. Accordingly, the appearance of the pH-dependent
transport of OCTN1 does not necessarily represent directly pH-
and/or proton-gradient-dependent transport, and that apparent pH
dependence might be affected by the experimental conditions, including
the gene expression method used.
The purpose of the present study was to confirm the driving force for OCTN1-mediated transport and to investigate further the functional properties of OCTN1-mediated transport of several cationic compounds by using two gene expression systems, Xenopus oocytes and HEK293 cells, to establish whether the transport characteristics are influenced by the experimental methods.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials. [1-14C]TEA bromide (2.4 mCi/mmol), p-[glycyl-1-14C]aminohippuric acid (53.1 mCi/mmol), and [N-methyl-3H]verapamil hydrochloride (78.6 Ci/mmol) were purchased from New England Nuclear (Boston, MA). L-[Methyl-3H]carnitine hydrochloride and [pyridinyl-5-3H]pyrilamine (28 Ci/mmol) were purchased from Amersham Pharmacia Biotech UK, Ltd. (Buckinghamshire, England). [9-3H]Quinidine (15 Ci/mmol) was from ARC Inc. (St. Louis, MO). All other chemicals were purchased from Sigma (St. Louis, MO) and Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
Transport Experiments in Xenopus Oocytes. Oocytes from Xenopus laevis were obtained by manual dissection in medium A (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES adjusted to pH 7.6 with NaOH) and defolliculated in modified Barth's solution (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 100 U/ml penicillin G, 100 mg/ml streptomycin, and 10 mM HEPES adjusted to pH 7.5 with NaOH).
Human OCTN1 cDNA (Tamai et al., 1997Uptake and Efflux Experiments by Transient Expression in HEK293 Cells. The construct pcDNA3/OCTN1 was used to transfect HEK293 cells (Japanese Cancer Research Resources Bank, Tokyo, Japan) according to the calcium phosphate precipitation method. HEK293 cells were routinely grown in Dulbecco's modified Eagle's medium containing 10% fetal calf serum (Gibco, Grand Island, NY), penicillin, and streptomycin in a humidified incubator at 37°C under 5% CO2. After 24 h cultivation of HEK293 cells in 10-cm dishes, pcDNA3/OCTN1 or pcDNA3 vector alone was transfected by adding 10 µg of the plasmid DNA per dish. At 48 h after transfection, the cells were harvested and suspended in transport medium containing 125 mM NaCl, 4.8 mM KCl, 5.6 mM D-glucose, 1.2 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, and 25 mM HEPES (pH 7.4).
In uptake experiments, cell suspension and a solution of a radiolabeled test compound in the transport medium were each incubated at 37°C for 20 min, then transport was initiated by mixing them. At appropriate times, 200-µl aliquots of the mixture were withdrawn and the cells were separated from the transport medium by centrifugal filtration through a layer of mixture of silicon oil and liquid paraffin with a density of 1.03. Each cell pellet was solubilized in 3 N KOH, neutralized with HCl, and the associated radioactivity was measured by means of a liquid scintillation counter. In the [14C]TEA efflux assay, HEK293 cells were preloaded with 0.5 µCi of [14C]TEA at 37°C for 10 min, then pelleted by centrifugation at 10,000 rpm for 10 s, and efflux was initiated by resuspending the cells in transport medium. At the indicated time, efflux was terminated by centrifugal filtration as described above. Cellular protein content was measured according to the method of Bradford (1976)Data Analysis. All data were expressed as mean ± S.E.M. and statistical analysis was performed by the use of Student's t test. The criterion of significance was taken to be P < .05.
| |
Results |
|---|
|
|
|---|
Expression of [14C]TEA Uptake in
Xenopus Oocytes Injected with Human OCTN1 cRNA.
To
confirm the expression of functional organic cation transport activity
of human OCTN1, we investigated the OCTN1-mediated [14C]TEA transport in a Xenopus
oocyte heterologous expression system. The uptake of
[14C]TEA in OCTN1 cRNA-injected oocytes was
significantly higher than that in water-injected oocytes on day 2 and
was further increased on days 3 and 4 after injection of the cRNA (Fig.
1). Subsequent uptake studies were
carried out more than 3 days after cRNA injection. Although the data
are not shown, uptake of [14C]TEA] by
Xenopus oocytes was linearly increased till 90 min and saturable with apparent Km and
Vmax values of 0.195 ± 0.033 mM and 18.5 ± 1.45 pmol/60 min/oocyte, respectively.
|
Effect of Membrane Potential on [14C]TEA Uptake in
Xenopus Oocytes.
We examined pH dependence of TEA
uptake by OCTN1 expressed in Xenopus oocytes. When the pH in
the transport medium was acidic (pH 6.0), OCTN1-mediated uptake of
[14C]TEA was decreased to about 40% of those
at neutral and alkaline pH, whereas no significant change in the uptake
of [14C]TEA was observed in water-injected
oocytes. Furthermore, comparable uptakes were observed at neutral and
alkaline pH (data not shown). The observation was comparable with that
observed in TEA transport by OCTN1 expressed in HEK293 cells (Tamai et
al., 1997
).
|
Effect of Extracellular pH on Efflux of [14C]TEA in HEK293 cells. Because it is important to know the driving force for TEA transport by OCTN1 to differentiate the physiological role on this transporter from those of the previously known OCT1 and OCT2, we further examined the effect of extracellular pH on TEA efflux from OCTN1-transfected HEK293 cells (Table 1). Efflux of [14C]TEA was initiated by incubating the cells preloaded with 150 µM [14C]TEA in the fresh medium at various pHs, and the efflux was evaluated from the remaining amount of [14C]TEA in the cells. Table 1 shows the time course of the amount of remaining [14C]TEA in the cells as the percentage of initial. The remaining amount of [14C]TEA at acidic pH 6.0 was minimum and increased with the increase of pH up to pH 8.0 over 5 min, demonstrating an enhanced efflux at acidic pH.
|
Inhibition of [14C]TEA Uptake by Various Cationic and Anionic Compounds in HEK293 Cells. The effect of various endogenous compounds and xenobiotics on the OCTN1-mediated [14C]TEA uptake in HEK293 cells is shown in Table 2. Various cationic compounds, such as choline, clonidine, cimetidine, nicotine, procainamide, pyrilamine, quinine, quinidine, and verapamil, had significant inhibitory effects (p < .05). Furthermore, zwitterionic compounds such as L- and D-carnitine and aminocephalosporin, cephaloridine and quinolone antibacterial agents, levofloxacin, and ofloxacin, were also significantly inhibitory, whereas other organic cations, such as NMN, guanidine, putrescine, spermine, and spermidine were not inhibitory. Cationic amino acids (L-arginine and L-lysine) and anionic compounds (p-aminohippurate and benzylpenicillin) were not inhibitory either.
|
Transport of Various Organic Cationic Compounds.
The substrate
selectivity of OCTN1 was assessed by measuring the uptake of
radiolabeled compounds by Xenopus oocytes expressing OCTN1,
because HEK293 cells exhibited significantly high background level of
uptake. As shown in Fig. 3, although
background uptakes were still rather high because of the binding,
nonmediated diffusion and/or native transport activity of
Xenopus oocytes, uptakes of [3H]quinidine,
[3H]pyrilamine,
[3H]verapamil, and
L-[3H]carnitine, as well
as [14C]TEA, by OCTN1 cRNA-injected oocytes
were apparently increased in comparison with those by water-injected
oocytes (p < .05). In contrast, the uptake of
[14C]benzylpenicillin by OCTN1 cRNA-injected
oocytes was not increased.
|
Effect of Extracellular TEA and Quinidine on Efflux of [14C]TEA in HEK293 Cells. To examine the specificity and direction of TEA transport, the effect of substrate/inhibitor of OCTN1 on the efflux of [14C]TEA from HEK293 cells was examined. When unlabeled TEA was included in the external medium, the intracellular [14C]TEA decreased faster than control, whereas in the presence of extracellular quinidine the remaining amount of [14C]TEA was kept high (Table 1). Effects of TEA and quinidine are explained by the enhancement of [14C]TEA efflux by an exchange transport with unlabeled TEA and inhibition of [14C]TEA efflux by quinidine, which is taken up by the HEK293 cells during efflux study rather than the enhancement by exchange transport, respectively. These observations suggest that efflux of [14C]TEA from the HEK293 cells is mediated by OCTN1 in a cation exchange mechanism.
| |
Discussion |
|---|
|
|
|---|
Recently, we cloned a novel organic cation transporter, human
OCTN1, which is strongly expressed in kidney and resulted in pH-dependent TEA uptake when expressed in HEK293 cells (Tamai et al.,
1997
). In the present study, we further investigated the precise
functional properties of organic cation transport by OCTN1 using two
gene expression systems, Xenopus oocytes and HEK293 cells.
OCTN1 cRNA-injected oocytes showed significantly enhanced transport of
[14C]TEA as compared with water-injected
oocytes. The Km for OCTN1-mediated TEA
uptake obtained in Xenopus oocytes (0.195 mM) was close to those of the previously characterized OCTN1-mediated TEA uptake in
HEK293 cells (0.436 mM; Tamai et al., 1997
) and in isolated brush-border membrane vesicles from rat and rabbit (0.15 ~ 0.8 mM; Takano et al., 1984
; Wright and Wunz, 1987
; Maeda et al., 1993
). In
addition, similar pH dependence in [14C]TEA
uptake by OCTN1 cRNA-injected oocytes to that by OCTN1-transfected HEK293 cells was observed (Tamai et al., 1997
). However, the uptake of
[14C]TEA in OCTN1 cRNA-injected oocytes was not
significantly affected upon replacement of Na+
with K+ (Fig. 2). The absence of potassium
replacement effect is quite distinct from the apparent pH- and
membrane potential-dependent transport as observed in OCT3 (Kekuda et
al., 1998
) and, therefore, suggests that the apparent pH-dependent
transport of TEA by OCTN1 is not accounted for by the change of
membrane potential. Moreover, [14C]TEA efflux
from OCTN1-transfected HEK293 cells was stimulated by an increase in
the proton concentration of the external medium (Table 1). Accordingly,
the transport of TEA by OCTN1 is presumably driven directly with a
movement of proton but not with an inside-negative membrane potential
difference as discussed in our previous observations obtained in a
mammalian gene expression system (Tamai et al., 1997
). The absence of
further increase of TEA uptake at an alkaline pH compared with neutral
pH is apparently comparable with the observation in TEA uptake by renal
brush-border membrane vesicles (Maegawa et al., 1988
). pH dependence
observed in OCTN1-mediated TEA uptake might be ascribed to at least two
underlying mechanisms, including activation by outwardly proton
gradient and by the presence of functionally optimal protonated form of
the transporter protein.
To determine the specificity of OCTN1, we examined the effect of various compounds on the initial uptake of [14C]TEA and the uptake of several organic cations that exhibited inhibitory effects on TEA uptake (Table 2 and Fig. 3). The initial uptake of [14C]TEA was significantly inhibited by a number of classical inhibitors on organic cation transport (cimetidine, procainamide, quinine, quinidine, and choline), other organic cationic compounds (clonidine, nicotine, pyrilamine, and verapamil) and zwitterionic compounds such as L-carnitine, aminocephalosporin (cephaloridine), and quinolone antibacterial agents (levofloxacin and ofloxacin), whereas p-aminohippuric acid and benzylpenicillin (typical substrates of organic anion transporter), L-arginine, L-lysine, and the endogenous polyamines spermine, spermidine, and putrescine had no inhibitory effect (Table 2). Moreover, we observed the increased uptake of several radiolabeled cationic compounds by expression of OCTN1 in Xenopus oocytes, suggesting that these cationic compounds as well as TEA are transported by OCTN1 and that the transporter may be multispecific. These data are consistent with previous observations on proton/organic cation transport in renal brush-border membrane vesicles in the human and other species. The absence of inhibition by guanidine suggested that OCTN1 is a pH-dependent transporter that has specificity for TEA and is different from the guanidine transporter in the renal proximal tubule.
TEA transport via OCTN1 was not inhibited by 5 mM NMN, suggesting a low
affinity of NMN for OCTN1, although many previous studies have
demonstrated that TEA and NMN appear to share the same proton/organic
cation transport system (Zhang et al., 1998
). However, Koepsell (1998)
suggested that the affinity of the proton/TEA antiporter for NMN is low
in renal proximal tubules, where a Ki value of 8.3 mM for NMN was obtained (David et al., 1995
). The difference among these results may be ascribed to experimental artifact, species differences, or the existence of multiple cation antiporters. Because of its broad substrate specificity, OCTN1 is
likely to play a significant role as a xenobiotic transporter and may
serve as a pharmacologically important multispecific cationic drug transporter.
Efflux of [14C]TEA was accelerated in the presence of the unlabeled TEA in the external medium, whereas quinidine caused a reduction of the efflux rate (Table 1). As clearly shown in Table 1 and Fig. 3, quinidine as well as TEA is a substrate of OCTN1 and has strong inhibitory potency to [14C]TEA transport by OCTN1. The uptake efficiency of TEA by OCTN1 expressed in Xenopus oocytes is about 32 times less than that of quinidine when evaluated by the cell per medium concentration ratios calculated from the results shown in Fig. 3. Accordingly, it is expected that quinidine added in the external medium accumulates extensively and rapidly into the intracellular space during the efflux of [14C]TEA and competitively inhibits efflux of [14C]TEA at the internal side of the cells. On the other hand, TEA accumulation does not occur in the extensive amount during efflux study and it hardly inhibits the efflux of [14C]TEA from the cells. Accordingly, an enhancement of efflux by the unlabeled TEA may represent countertransport effect, suggesting that OCTN1-mediated TEA transport is symmetrical and is explained by cation/cation exchange mechanism.
Wu et al. (1998)
and we (Tamai et al., 1998
) have successfully cloned
OCTN2, an isoform of OCTN1. Wu et al. (1998)
reported a pH-dependent
TEA transport via OCTN2, whereas we found that OCTN2 predominantly
transports L-[3H]carnitine in a
sodium-dependent manner in OCTN2-transfected HEK293 cells, with only a
low activity of TEA transport (Tamai et al., 1998
). Furthermore,
physiological importance of OCTN2 as the carnitine transporter was
demonstrated in our recent study on carnitine-deficient patients and
mice (Nezu et al., 1999
). In the present study,
[14C]TEA transport via OCTN1 was significantly
inhibited by L- and D-carnitine and
L-carnitine was transported by OCTN1. Accordingly, the
common physiological role of OCTN1 and OCTN2 might be transport of
carnitine in several tissues, although carnitine transport by OCTN1
will need to be functionally characterized further.
In conclusion, OCTN1 was demonstrated to be a multispecific, bidirectional, and pH-dependent organic cation transporter that is presumably energized by proton antiport mechanism in renal epithelial cells, although its subcellular localization is not clear at present. In addition, the broad substrate specificity of OCTN1 suggests a crucial role of the transporter in facilitating the elimination of xenobiotics. Furthermore, expression of OCTN1 in oocytes and HEK293 cells is expected to be useful for the development of in vitro assay systems for drug elimination and drug/drug interaction studies.
| |
Footnotes |
|---|
Accepted for publication December 29, 1998.
Received for publication September 14, 1998.
1 This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture.
Send reprint requests to: Prof. Akira Tsuji, Department of Pharmacobio-Dynamics, Faculty of Pharmaceutical Sciences, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-0934, Japan. E-mail: tsuji{at}kenroku.kanazawa-u.ac.jp
| |
Abbreviations |
|---|
TEA, tetraethylammonium; NMN, N1-methylnicotinamide.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Z. Ma, J. Wang, R. L. Nation, J. Li, J. D. Turnidge, K. Coulthard, and R. W. Milne Renal Disposition of Colistin in the Isolated Perfused Rat Kidney Antimicrob. Agents Chemother., July 1, 2009; 53(7): 2857 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Garrett, S. Xu, P. A. Simmons, J. Vehige, J. L. Flanagan, and M. D. Willcox Expression and Localization of Carnitine/Organic Cation Transporter OCTN1 and OCTN2 in Ocular Epithelium Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4844 - 4849. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ling and J. Alcorn Acute Administration of Cefepime Lowers L-Carnitine Concentrations in Early Lactation Stage Rat Milk J. Nutr., July 1, 2008; 138(7): 1317 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, I. Tamai, Y. Sai, K. Yoshida, T. Wakayama, Y. Kido, J.-i. Nezu, S. Iseki, and A. Tsuji Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa Reproduction, November 1, 2007; 134(5): 651 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, N. J. Cherrington, and S. H. Wright Molecular identification and functional characterization of rabbit MATE1 and MATE2-K Am J Physiol Renal Physiol, July 1, 2007; 293(1): F360 - F370. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maeda, M. Hirayama, D. Kobayashi, K. Miyazawa, and I. Tamai Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines Drug Metab. Dispos., March 1, 2007; 35(3): 394 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Watanabe, Y. Kato, T. Sugiura, Y. Kubo, T. Wakayama, S. Iseki, and A. Tsuji PDZ Adaptor Protein PDZK2 Stimulates Transport Activity of Organic Cation/Carnitine Transporter OCTN2 by Modulating Cell Surface Expression Drug Metab. Dispos., November 1, 2006; 34(11): 1927 - 1934. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kato, M. Sugiura, T. Sugiura, T. Wakayama, Y. Kubo, D. Kobayashi, Y. Sai, I. Tamai, S. Iseki, and A. Tsuji Organic Cation/Carnitine Transporter OCTN2 (Slc22a5) Is Responsible for Carnitine Transport across Apical Membranes of Small Intestinal Epithelial Cells in Mouse Mol. Pharmacol., September 1, 2006; 70(3): 829 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alnouti, J. S. Petrick, and C. D. Klaassen TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE Drug Metab. Dispos., March 1, 2006; 34(3): 477 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kwok, A. Yamauchi, R. Rajesan, L. Chan, U. Dhillon, W. Gao, H. Xu, B. Wang, S. Takahashi, J. Semple, et al. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, M. Irokawa, T. Maeda, A. Tsuji, and I. Tamai Carnitine/organic cation transporter OCTN2-mediated transport of carnitine in primary-cultured epididymal epithelial cells Reproduction, December 1, 2005; 130(6): 931 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, A. Goto, T. Maeda, J.-i. Nezu, A. Tsuji, and I. Tamai OCTN2-mediated transport of carnitine in isolated Sertoli cells Reproduction, June 1, 2005; 129(6): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grundemann, S. Harlfinger, S. Golz, A. Geerts, A. Lazar, R. Berkels, N. Jung, A. Rubbert, and E. Schomig Discovery of the ergothioneine transporter PNAS, April 5, 2005; 102(14): 5256 - 5261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hukkanen, P. Jacob III, and N. L. Benowitz Metabolism and Disposition Kinetics of Nicotine Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kato, Y. Sai, K. Yoshida, C. Watanabe, T. Hirata, and A. Tsuji PDZK1 Directly Regulates the Function of Organic Cation/Carnitine Transporter OCTN2 Mol. Pharmacol., March 1, 2005; 67(3): 734 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rytting and K. L. Audus Novel Organic Cation Transporter 2-Mediated Carnitine Uptake in Placental Choriocarcinoma (BeWo) Cells J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 192 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lahjouji, I. Elimrani, J. Lafond, L. Leduc, I. A. Qureshi, and G. A. Mitchell L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2 Am J Physiol Cell Physiol, August 1, 2004; 287(2): C263 - C269. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imaoka, H. Kusuhara, S. Adachi-Akahane, M. Hasegawa, N. Morita, H. Endou, and Y. Sugiyama The Renal-Specific Transporter Mediates Facilitative Transport of Organic Anions at the Brush Border Membrane of Mouse Renal Tubules J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2012 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishiguro, T. Nozawa, A. Tsujihata, A. Saito, W. Kishimoto, K. Yokoyama, T. Yotsumoto, K. Sakai, T. Igarashi, and I. Tamai INFLUX AND EFFLUX TRANSPORT OF H1-ANTAGONIST EPINASTINE ACROSS THE BLOOD-BRAIN BARRIER Drug Metab. Dispos., May 1, 2004; 32(5): 519 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. di San Filippo, Y. Wang, and N. Longo Functional Domains in the Carnitine Transporter OCTN2, Defective in Primary Carnitine Deficiency J. Biol. Chem., November 28, 2003; 278(48): 47776 - 47784. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Poola, M. Kalis, F. M. Plakogiannis, and D. R. Taft Characterization of pentamidine excretion in the isolated perfused rat kidney J. Antimicrob. Chemother., September 1, 2003; 52(3): 397 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tanaka, K. Deai, M. Inagaki, and A. Ichikawa Uptake of histamine by mouse peritoneal macrophages and a macrophage cell line, RAW264.7 Am J Physiol Cell Physiol, September 1, 2003; 285(3): C592 - C598. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Elimrani, K. Lahjouji, E. Seidman, M.-J. Roy, G. A. Mitchell, and I. Qureshi Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G863 - G871. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alcorn, X. Lu, J. A. Moscow, and P. J. McNamara Transporter Gene Expression in Lactating and Nonlactating Human Mammary Epithelial Cells Using Real-Time Reverse Transcription-Polymerase Chain Reaction J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 487 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lee, C. Ng, K. L. R. Brouwer, and D. R. Thakker Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ohashi, I. Tamai, A. Inano, M. Katsura, Y. Sai, J.-i. Nezu, and A. Tsuji Studies on Functional Sites of Organic Cation/Carnitine Transporter OCTN2 (SLC22A5) Using a Ser467Cys Mutant Protein J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1286 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kristufek, W. Rudorfer, C. Pifl, and S. Huck Organic cation transporter mRNA and function in the rat superior cervical ganglion J. Physiol., August 15, 2002; 543(1): 117 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rodriguez, J. C. Labus, and B. T. Hinton Organic Cation/Carnitine Transporter, OCTN2, Is Differentially Expressed in the Adult Rat Epididymis Biol Reprod, July 1, 2002; 67(1): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cova, U. Laforenza, G. Gastaldi, Y. Sambuy, S. Tritto, A. Faelli, and U. Ventura Guanidine Transport across the Apical and Basolateral Membranes of Human Intestinal Caco-2 Cells Is Mediated by Two Different Mechanisms J. Nutr., July 1, 2002; 132(7): 1995 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Motohashi, Y. Sakurai, H. Saito, S. Masuda, Y. Urakami, M. Goto, A. Fukatsu, O. Ogawa, and K.-i. Inui Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney J. Am. Soc. Nephrol., April 1, 2002; 13(4): 866 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer, and C. D. Klaassen Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels Drug Metab. Dispos., February 1, 2002; 30(2): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Sweet, D. S. Miller, and J. B. Pritchard Ventricular Choline Transport. A ROLE FOR ORGANIC CATION TRANSPORTER 2 EXPRESSED IN CHOROID PLEXUS J. Biol. Chem., November 2, 2001; 276(45): 41611 - 41619. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Han, D. H. Sweet, D.-N. Hu, and J. B. Pritchard Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 450 - 457. [Abstract] [Full Text] |
||||
![]() |
R. Ohashi, I. Tamai, J.-i. Nezu, H. Nikaido, N. Hashimoto, A. Oku, Y. Sai, M. Shimane, and A. Tsuji Molecular and Physiological Evidence for Multifunctionality of Carnitine/Organic Cation Transporter OCTN2 Mol. Pharmacol., February 1, 2001; 59(2): 358 - 366. [Abstract] [Full Text] |
||||
![]() |
D. H. Sweet, D. S. Miller, and J. B. Pritchard Basolateral localization of organic cation transporter 2 in intact renal proximal tubules Am J Physiol Renal Physiol, November 1, 2000; 279(5): F826 - F834. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wagner, U. Lukewille, S. Kaltenbach, I. Moschen, A. Broer, T. Risler, S. Broer, and F. Lang Functional and pharmacological characterization of human Na+-carnitine cotransporter hOCTN2 Am J Physiol Renal Physiol, September 1, 2000; 279(3): F584 - F591. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ganapathy, P. D. Prasad, M. E. Ganapathy, and F. H. Leibach Placental Transporters Relevant to Drug Distribution across the Maternal-Fetal Interface J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 413 - 420. [Full Text] |
||||
![]() |
H. Mizuuchi, T. Katsura, K. Ashida, Y. Hashimoto, and K.-I. Inui Diphenhydramine transport by pH-dependent tertiary amine transport system in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G563 - G569. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tamai, R. Ohashi, J.-i. Nezu, Y. Sai, D. Kobayashi, A. Oku, M. Shimane, and A. Tsuji Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice J. Biol. Chem., December 15, 2000; 275(51): 40064 - 40072. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pietig, T. Mehrens, J. R. Hirsch, I. Cetinkaya, H. Piechota, and E. Schlatter Properties and Regulation of Organic Cation Transport in Freshly Isolated Human Proximal Tubules J. Biol. Chem., August 31, 2001; 276(36): 33741 - 33746. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||